512 related articles for article (PubMed ID: 23987460)
1. Polyamidoamine dendrimer conjugated chitosan nanoparticles for the delivery of methotrexate.
Leng ZH; Zhuang QF; Li YC; He Z; Chen Z; Huang SP; Jia HY; Zhou JW; Liu Y; Du LB
Carbohydr Polym; 2013 Oct; 98(1):1173-8. PubMed ID: 23987460
[TBL] [Abstract][Full Text] [Related]
2. Carboxymethyl chitosan-poly(amidoamine) dendrimer core-shell nanoparticles for intracellular lysozyme delivery.
Zhang X; Zhao J; Wen Y; Zhu C; Yang J; Yao F
Carbohydr Polym; 2013 Nov; 98(2):1326-34. PubMed ID: 24053810
[TBL] [Abstract][Full Text] [Related]
3. Octreotide-conjugated PAMAM for targeted delivery to somatostatin receptors over-expressed tumor cells.
Peng J; Qi X; Chen Y; Ma N; Zhang Z; Xing J; Zhu X; Li Z; Wu Z
J Drug Target; 2014 Jun; 22(5):428-38. PubMed ID: 24437350
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and characterization of dendritic star-shaped zwitterionic polymers as novel anticancer drug delivery carriers.
Li L; Wang Y; Ji F; Wen Y; Li J; Yang B; Yao F
J Biomater Sci Polym Ed; 2014; 25(14-15):1641-57. PubMed ID: 25025700
[TBL] [Abstract][Full Text] [Related]
5. Novel water-soluble and pH-responsive anticancer drug nanocarriers: doxorubicin-PAMAM dendrimer conjugates attached to superparamagnetic iron oxide nanoparticles (IONPs).
Chang Y; Meng X; Zhao Y; Li K; Zhao B; Zhu M; Li Y; Chen X; Wang J
J Colloid Interface Sci; 2011 Nov; 363(1):403-9. PubMed ID: 21821262
[TBL] [Abstract][Full Text] [Related]
6. Inclusion of a pH-responsive amino acid-based amphiphile in methotrexate-loaded chitosan nanoparticles as a delivery strategy in cancer therapy.
Nogueira DR; Scheeren LE; Macedo LB; Marcolino AI; Pilar Vinardell M; Mitjans M; Rosa Infante M; Farooqi AA; Rolim CM
Amino Acids; 2016 Jan; 48(1):157-68. PubMed ID: 26306845
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate-loaded PEGylated chitosan nanoparticles: synthesis, characterization, and in vitro and in vivo antitumoral activity.
Chen J; Huang L; Lai H; Lu C; Fang M; Zhang Q; Luo X
Mol Pharm; 2014 Jul; 11(7):2213-23. PubMed ID: 24164427
[TBL] [Abstract][Full Text] [Related]
8. Chitosan Engineered PAMAM Dendrimers as Nanoconstructs for the Enhanced Anti-Cancer Potential and Improved In vivo Brain Pharmacokinetics of Temozolomide.
Sharma AK; Gupta L; Sahu H; Qayum A; Singh SK; Nakhate KT; Ajazuddin ; Gupta U
Pharm Res; 2018 Jan; 35(1):9. PubMed ID: 29294212
[TBL] [Abstract][Full Text] [Related]
9. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors.
Bilensoy E; Sarisozen C; Esendağli G; Doğan AL; Aktaş Y; Sen M; Mungan NA
Int J Pharm; 2009 Apr; 371(1-2):170-6. PubMed ID: 19135514
[TBL] [Abstract][Full Text] [Related]
10. Zwitterionic chitosan-polyamidoamine dendrimer complex nanoparticles as a pH-sensitive drug carrier.
Liu KC; Yeo Y
Mol Pharm; 2013 May; 10(5):1695-704. PubMed ID: 23510114
[TBL] [Abstract][Full Text] [Related]
11. Cationic nanoparticles self-assembled from amphiphilic chitosan derivatives containing poly(amidoamine) dendrons and deoxycholic acid as a vector for co-delivery of doxorubicin and gene.
Chen S; Deng J; Zhang LM
Carbohydr Polym; 2021 Apr; 258():117706. PubMed ID: 33593576
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of amphiphilic glycidol-chitosan-deoxycholic acid nanoparticles as a drug carrier for doxorubicin.
Zhou H; Yu W; Guo X; Liu X; Li N; Zhang Y; Ma X
Biomacromolecules; 2010 Dec; 11(12):3480-6. PubMed ID: 21028798
[TBL] [Abstract][Full Text] [Related]
13. Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex.
Patri AK; Kukowska-Latallo JF; Baker JR
Adv Drug Deliv Rev; 2005 Dec; 57(15):2203-14. PubMed ID: 16290254
[TBL] [Abstract][Full Text] [Related]
14. PAMAM conjugated chitosan through naphthalimide moiety for enhanced gene transfection efficiency.
Sarkar K; Kundu PP
Carbohydr Polym; 2013 Oct; 98(1):495-504. PubMed ID: 23987374
[TBL] [Abstract][Full Text] [Related]
15. Cellular uptake of glucoheptoamidated poly(amidoamine) PAMAM G3 dendrimer with amide-conjugated biotin, a potential carrier of anticancer drugs.
Uram Ł; Szuster M; Filipowicz A; Zaręba M; Wałajtys-Rode E; Wołowiec S
Bioorg Med Chem; 2017 Jan; 25(2):706-713. PubMed ID: 27919613
[TBL] [Abstract][Full Text] [Related]
16. Design of interior-functionalized fully acetylated dendrimers for anticancer drug delivery.
Hu J; Su Y; Zhang H; Xu T; Cheng Y
Biomaterials; 2011 Dec; 32(36):9950-9. PubMed ID: 21944725
[TBL] [Abstract][Full Text] [Related]
17. Bio-stimuli-responsive multi-scale hyaluronic acid nanoparticles for deepened tumor penetration and enhanced therapy.
Huo M; Li W; Chaudhuri AS; Fan Y; Han X; Yang C; Wu Z; Qi X
Carbohydr Polym; 2017 Sep; 171():173-182. PubMed ID: 28578951
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo uptake studies of PAMAM G4.5 dendrimers in breast cancer.
Oddone N; Lecot N; Fernández M; Rodriguez-Haralambides A; Cabral P; Cerecetto H; Benech JC
J Nanobiotechnology; 2016 Jun; 14(1):45. PubMed ID: 27297021
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of anionic half generation 3.5-6.5 poly(amidoamine) dendrimers as delivery vehicles for the active component of the anticancer drug cisplatin.
Kirkpatrick GJ; Plumb JA; Sutcliffe OB; Flint DJ; Wheate NJ
J Inorg Biochem; 2011 Sep; 105(9):1115-22. PubMed ID: 21704583
[TBL] [Abstract][Full Text] [Related]
20. Functionalization of magnetic nanoparticles with dendritic-linear-brush-like triblock copolymers and their drug release properties.
He X; Wu X; Cai X; Lin S; Xie M; Zhu X; Yan D
Langmuir; 2012 Aug; 28(32):11929-38. PubMed ID: 22799877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
